Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Glycoprotein – e.g. – mucins – proteoglycans – etc.
Patent
1990-01-09
1993-04-20
Nucker, Christine M.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Glycoprotein, e.g., mucins, proteoglycans, etc.
53038885, 530828, 435723, 436501, 436548, 436813, C07K 1514
Patent
active
052044505
ABSTRACT:
Disclosed is a glycoprotein, CORA, which has a binding affinity for carcinoembryonic antigen (CEA). This glycoprotein is a marker for carcinoma, and can be characterized by having a molecular weight of about 46,000-50,000 daltons, an isoelectric point of about 3.0-3.5, a carbohydrate content of about 25-35% by weight, reactivity with antisera raised thereto, and substantially no reactivity with antisera raised to nonspecific cross-reacting antigen (NCA) or to CEA. Also disclosed are a hybridoma which produces a monoclonal antibody to CORA, the monoclonal antibody to CORA, and a device, kit, and method for detecting and monitoring carcinoma.
REFERENCES:
patent: 4489167 (1984-12-01), Ochi et al.
patent: 4612121 (1986-09-01), Hermansson
patent: 4687734 (1987-08-01), Chester
patent: 4708930 (1987-11-01), Kortright et al.
patent: 4914021 (1990-04-01), Toth et al.
Krupey et al. (1972) Biochem. 9:617-622.
Toth et al. (1985) Cancer Research, 45:392-397.
Ziegler et al. (1982) Cancer Research, 42:1567-1573.
Fink et al. (1982) Cancer Research, 42:1574-1578.
Ochi et al. (1984) Clinica. Chemica. Acta, 138:9-19.
Rudman et al. (1972) Cancer Reserach, 32:1951-1959.
Toth et al. (1982) Biochem J., 204:377-381.
Ochi et al. (1982) Clinica. Chemica. Aca., 122:145-160.
Ochi et al. (1983) Cancer Letters, 20:173-182.
Ura et al. (1985) Cancer Letters, 25:283-295.
Toth et al. (Jun. 1987) Am. Soc. Biol. Chemists., ab. No. 1110, p. 2116.
Toth et al. (1988) 1988 FASEB Abstract Form.
Ochi et al. (1982) Journal of Immunological Methods, 52:213-221.
Thomas Peter
Toth Carol A.
New England Deaconess Hospital Corporation
Nucker Christine M.
LandOfFree
Carcinoma orosomucoid-related antigen, a monoclonal antibody the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carcinoma orosomucoid-related antigen, a monoclonal antibody the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carcinoma orosomucoid-related antigen, a monoclonal antibody the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1527042